Letrix (Letrozole)

Letrozole blocks the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. By lowering circulating estrogen levels, it deprives estrogen‑dependent breast cancer cells of a key growth signal, thereby inhibiting tumor progression.

The dose of Letrix is determined by the prescribing clinician based on the patient’s clinical condition, renal and hepatic function, and treatment intent. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed.

Letrix is classified as Pregnancy Category X, meaning it is contraindicated in pregnant women because it can cause fetal harm. Breastfeeding is not recommended, as letrozole may be excreted in milk and affect the infant.

To order Letrix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrix (letrozole) belongs to the aromatase inhibitor class, similar to anastrozole and exemestane. Compared with tamoxifen, another endocrine therapy, letrozole generally offers stronger estrogen suppression in postmenopausal patients, but each agent has a distinct safety profile that guides selection.

Letrix should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Letrix is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional to ensure consistent absorption.

Serious risks include severe liver injury, osteoporosis‑related fractures, and thromboembolic events such as deep‑vein thrombosis or pulmonary embolism. Patients should report any signs of jaundice, sudden bone pain, swelling of the limbs, or shortness of breath to their physician promptly.

Letrix is contraindicated in premenopausal women, pregnant or breastfeeding individuals, and anyone with known hypersensitivity to letrozole or other aromatase inhibitors. Patients with uncontrolled liver disease or severe cardiovascular conditions should also avoid its use unless specifically directed by a specialist.